Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

RMJ. 2024; 49(3): 656-660


Comparison of nigella sativa and pioglitazone on hyperglycemia, adiponectin and resistin in streptozotocin induced diabetic mice

Ghulam Mustafa Lodhi, Ayesha Shafqat, Beenish Zafar, Misbah Batool, Roomisa Anis, Azhar Ali Kazmi.




Abstract

Objective: To compare the effects of nigella sativa and pioglitazone on hyperglycemia, hyperlipidemia, adiponectin and resistin in streptozotocin induced diabetic mice.
Methodology: This quasi-experimental study was conducted from June 2021 to May 2022. Thirty mice were obtained. Fifteen were included in each of the two groups. Mice were given high fat diet for 8 weeks followed by low dose of streptozotocin injection intraperitoneally. After confirmation of diabetes, mice were enrolled for further study. Nigella sativa and pioglitazone in doses of 300 mg/kg and 30mg/kg were given by gavage tube once daily for 16 weeks. Blood glucose, adiponectin, resistin, cholesterol and triglycerides levels were observed after 16 weeks in both the groups. Statistical analyses were done by SPSS version 20.
Results: There were statistically significant changes in blood glucose, adiponectin, resistin, cholesterol and triglycerides levels in diabetic mice given pioglitazone as compared to those who received nigella sativa ethanolic extraction (p

Key words: Diabetes mellitus, adipokines, thiazolidinediones.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.